Catalent’s China expansion to meet growing clinical trial industry
Catalent’s existing clinical packaging facility in Shanghai is nearing the end of its expansion, ready to meet the needs of the growing Asia-Pacific region.
Catalent’s existing clinical packaging facility in Shanghai is nearing the end of its expansion, ready to meet the needs of the growing Asia-Pacific region.
The CRO Calvert Laboratories is sponsoring a Boston-based coworking launchpad and will provide various services to the lab’s tenants.
Teva’s EpiPen generic will reach market at a cost of $300 per pack, which matches the price of Mylan’s own generic version.
South Korean biotech ABL Bio has selected WuXi Biologics to develop and manufacture up to eight bispecific antibodies for the clinic.
Aquestive’s NDA to the US FDA was knocked back over API issues, but the company still expects the product to be available by 2020.
UPDATE
Novartis has announced plans to move its UK headquarters to an ‘emerging life sciences cluster’ in West London, 50 minutes’ drive from its current location in Surrey.